Korea Asset Investment Securities Co., Ltd. (KOSDAQ:190650)
9,680.00
-610.00 (-5.93%)
At close: Feb 27, 2026
KOSDAQ:190650 Revenue
Korea Asset Investment Securities had revenue of 58.88B KRW in the quarter ending December 31, 2025, a decrease of -22.41%. This brings the company's revenue in the last twelve months to 239.47B, down -3.46% year-over-year. In the fiscal year ending March 31, 2025, Korea Asset Investment Securities had annual revenue of 248.07B with 22.70% growth.
Revenue (ttm)
239.47B
Revenue Growth
-3.46%
P/S Ratio
0.26
Revenue / Employee
n/a
Employees
n/a
Market Cap
61.84B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2025 | 248.07B | 45.90B | 22.70% |
| Mar 31, 2024 | 202.17B | -8.75B | -4.15% |
| Mar 31, 2023 | 210.92B | 3.38B | 1.63% |
| Mar 31, 2022 | 207.54B | 53.09B | 34.37% |
| Mar 31, 2021 | 154.46B | -56.58B | -26.81% |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| RP Bio | 134.21B |
| Dukshinepc | 107.86B |
| M eighty-three | 100.96B |
| Coreana Cosmetics | 76.53B |
| Kyung Nam Pharm | 56.18B |
| Nature & Environment | 40.32B |
| POINT ENGINEERING | 34.64B |
| SOOSAN INT | 23.89B |